Edition:
United Kingdom

Amyris Inc (AMRS.OQ)

AMRS.OQ on NASDAQ Stock Exchange Global Select Market

4.03USD
6:07pm BST
Change (% chg)

$0.10 (+2.54%)
Prev Close
$3.93
Open
$3.95
Day's High
$4.07
Day's Low
$3.80
Volume
50,531
Avg. Vol
633,588
52-wk High
$9.28
52-wk Low
$1.87

Latest Key Developments (Source: Significant Developments)

Amyris Appoints Kathleen Valiasek Chief Business Officer
Tuesday, 4 Jun 2019 

June 4 (Reuters) - Amyris Inc ::AMYRIS APPOINTS KATHLEEN VALIASEK CHIEF BUSINESS OFFICER-APPOINTS JONATHAN WOLTER AS INTERIM CFO.AMYRIS INC - APPOINTMENT OF KATHLEEN VALIASEK, FORMERLY CHIEF FINANCIAL OFFICER, TO CHIEF BUSINESS OFFICER IS EFFECTIVE IMMEDIATELY.  Full Article

Amyris Files For Non-Timely 10-Q With U.S. SEC
Monday, 13 May 2019 

May 13 (Reuters) - Amyris Inc ::AMYRIS FILES FOR NON-TIMELY 10-Q WITH U.S. SEC.AMYRIS - IN PROCESS OF FINALIZING ITS EVALUATION OF INTERNAL CONTROL OVER FINANCIAL REPORTING.AMYRIS -EXPECTS TO REPORT MATERIAL WEAKNESSES IN ADDITION TO MATERIAL WEAKNESS REPORTED IN ANNUAL REPORT ON 10-K FOR FISCAL YEAR ENDED DEC 31, 2017.AMYRIS - REACHED CONCLUSION THAT ITS SYSTEM OF INTERNAL CONTROL OVER FINANCIAL REPORTING IS NOT EFFECTIVE AS OF DECEMBER 31, 2018.AMYRIS - EXPECTS TO CONTINUE TO REPORT THAT THERE IS SUBSTANTIAL DOUBT ABOUT ITS ABILITY TO CONTINUE AS A GOING CONCERN.  Full Article

Amyris Inc, GACP, Foris Ventures Enter A Loan Purchase Agreement
Wednesday, 17 Apr 2019 

April 17 (Reuters) - Amyris Inc ::AMYRIS INC - ON APRIL 15, COMPANY, GACP, FORIS VENTURES ENTERED INTO A LOAN PURCHASE AGREEMENT.AMYRIS INC - FORIS AGREED TO PURCHASE OUTSTANDING LOANS UNDER LSA AND ALL DOCUMENTS AND ASSETS RELATED THERETO FROM GACP..AMYRIS INC - COMPANY AGREED TO REPAY FORIS $2.5 MILLION OF PURCHASE PRICE PAID BY FORIS TO GACP PURSUANT TO LPA..  Full Article

Amyris Says "Working Diligently To Resolve Its 9.5% Convertible Notes Due April 2019"
Monday, 15 Apr 2019 

April 15 (Reuters) - Amyris Inc ::AMYRIS PROVIDES UPDATE ON RESOLUTION OF APRIL 2019 CONVERTIBLE NOTE MATURITY.AMYRIS INC - "WORKING DILIGENTLY TO RESOLVE ITS 9.5% CONVERTIBLE NOTES DUE APRIL 2019".AMYRIS INC - PLANNED EQUITY INVESTMENT FROM FORIS VENTURES, IS ANTICIPATED TO PROVIDE A PORTION OF CASH NEEDED TO SATISFY NOTES.AMYRIS - PLANS TO REPAY CONVERTIBLE NOTES DUE APRIL 2019 WITH CASH FROM A BUSINESS TRANSACTION AS WELL AS NET PROCEEDS OF A PLANNED EQUITY INVESTMENT.AMYRIS INC - PLANNED EQUITY INVESTMENT FROM FORIS VENTURES IS ANTICIPATED TO PROVIDE A PORTION OF CASH NEEDED TO SATISFY NOTES.AMYRIS INC - COMPANY EXPECTS THAT 9.5% CONVERTIBLE NOTES WILL BE REPAID AND RETIRED IN FULL..  Full Article

Amyris Inc On April 8 Entered Into A Credit Agreement With Foris Ventures For Aggregate Of $8 Mln
Thursday, 11 Apr 2019 

April 11 (Reuters) - Amyris Inc ::AMYRIS INC - ON APRIL 8 ENTERED INTO A CREDIT AGREEMENT WITH FORIS VENTURES FOR AGGREGATE OF $8 MILLION.AMYRIS SAYS FORIS NOTE HAS A MATURITY DATE OF OCTOBER 14 - SEC FILING.AMYRIS INC - NON-RELIANCE ON PREVIOUSLY ISSUED FINANCIAL STATEMENTS OR A RELATED AUDIT REPORT OR COMPLETED INTERIM REVIEW..AMYRIS INC - A MATERIAL ERROR WAS MADE RELATED TO ESTIMATES FOR RECOGNIZING REVENUE FOR ROYALTY PAYMENTS UNDER THE VALUE SHARING AGREEMENT WITH DSM.AMYRIS INC - ANTICIPATES REVENUE FOR FISCAL 2018, AS COMPARED TO RESULTS INCLUDED IN MARCH 18, RELEASE, WILL BE REDUCED BY ABOUT $12 MILLION TO $16 MILLION.AMYRIS - ANTICIPATES NET INCOME FOR FISCAL 2018, AS COMPARED TO RESULTS INCLUDED IN MARCH 18, RELEASE, WILL BE REDUCED BY ABOUT $7 MILLION TO $11 MILLION.AMYRIS - EXPECTS RESTATEMENT FOR MATERIAL ERRORS, CERTAIN OTHER MATTERS WILL INCLUDE REDUCTION IN REVENUE & INCREASE IN NET LOSS FOR NON-RELIANCE PERIODS.  Full Article

Loyola Capital Management Reports 10.82 Pct Passive Stake In Amyris
Thursday, 28 Mar 2019 

March 28 (Reuters) - Amyris Inc ::LOYOLA CAPITAL MANAGEMENT REPORTS A 10.82 PERCENT PASSIVE STAKE IN AMYRIS AS OF MARCH 26 - SEC FILING.  Full Article

Amyris Files For Non-Timely 10-K With U.S. SEC
Tuesday, 19 Mar 2019 

March 19 (Reuters) - Amyris Inc ::AMYRIS FILES FOR NON-TIMELY 10-K WITH U.S. SEC.  Full Article

Amyris Announces $255 Mln Cannabinoid Development, Licensing & Commercialization Agreement
Tuesday, 5 Feb 2019 

Feb 5 (Reuters) - Amyris Inc ::AMYRIS ANNOUNCES $255 MILLION CANNABINOID DEVELOPMENT, LICENSING AND COMMERCIALIZATION AGREEMENT − REPRESENTS LARGEST COLLABORATION AGREEMENT TO DATE FOR AMYRIS.AMYRIS INC - $255 MILLION IN PAYMENTS INCLUDE AN UPFRONT PAYMENT.AMYRIS INC - REMAINDER OF PAYMENTS LINKED TO MILESTONES THAT ARE EXPECTED OVER NEXT 12-36 MONTHS FOLLOWING SIGNING OF A DEFINITIVE FINAL AGREEMENT.AMYRIS - DEVELOPMENT TO BEGIN IMMEDIATELY & COMMERCIALIZATION OF PRODUCTS EXPECTED WITHIN NEXT 18-24 MONTHS ASSUMING APPROPRIATE REGULATORY APPROVALS.AMYRIS INC - PARTNER WILL BE GRANTED A LICENSE TO COMMERCIALIZE PRODUCTS.AMYRIS INC - "AMYRIS WILL BE ELIGIBLE TO RECEIVE SUBSTANTIAL ONGOING ROYALTY PAYMENTS" FROM DEAL.AMYRIS INC - COMMITTED TO EXECUTING FINAL DEFINITIVE AGREEMENT BY END OF MARCH.  Full Article

Amyris Files Prospectus Relating To Registration For Potential Offer, Sale Of Up To 19.5 Million Shares Of Common Stock By Selling Stockholders
Tuesday, 8 Jan 2019 

Jan 8 (Reuters) - Amyris Inc ::AMYRIS - FILES PROSPECTUS RELATING TO REGISTRATION FOR POTENTIAL OFFER, SALE OF UP TO 19.5 MILLION SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS.  Full Article

Amyris Announces Signing Of Nutritional Product Royalty Agreement
Monday, 31 Dec 2018 

Dec 31 (Reuters) - Amyris Inc ::AMYRIS ANNOUNCES SIGNING OF NUTRITIONAL PRODUCT ROYALTY AGREEMENT.AMYRIS INC - SIGNED A LONG-TERM AGREEMENT WITH XINFU OF CHINA FOR A SIGNIFICANT INITIAL PAYMENT AND A LONG-TERM MINIMUM ANNUAL SHARE.AMYRIS INC - AGREEMENT WITH XINFU OF CHINA FOR LONG-TERM MINIMUM ANNUAL SHARE OF AN EXISTING NUTRITIONAL PRODUCT ROYALTY ARRANGEMENT.AMYRIS INC - AGREEMENT INCLUDES MATERIAL UPFRONT PAYMENT EQUAL TO $50 MILLION EXPECTATION SET BY CO DURING Q3 EARNINGS CALL.  Full Article